semaglutide and the amylin analog cagrilintide Once-weekly for weight management in people with overweight obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial Cagrilintide: Weekly Amylin Analog —

Very common (may affect more than 1 in 10 people): Nausea Vomiting Diarrhoea Constipation Abdominal (stomach) pain Headache Tiredness (fatigue) Low blood sugar (hypoglycaemia) in people with type 2 diabetes Common (may affect up to 1 in 10 people): Low blood sugar in people without type 2 diabetes Dizziness Altered taste (dysgeusia) and altered skin sensation (dysaesthesia) Indigestion (dyspepsia), heartburn / acid reflux (GORD), gastritis, burping, wind (flatulence) and bloating Increased heart rate Gallstones (cholelithiasis) Kidney stones (urolithiasis) Hair loss Increased blood levels of amylase, lipase and bilirubin Diabetic retinopathy in people with type 2 diabetes Hip fracture Uncommon to rare: Acute pancreatitis (inflammation of the pancreas) Low blood pressure (hypotension) and orthostatic hypotension Allergic reactions, including anaphylactic reaction and angioedema (swelling) Delayed gastric emptying and, rarely, intestinal obstruction Non-arteritic anterior ischaemic optic neuropathy (NAION), a rare eye condition that can cause sudden loss of vision Serious side effects

Gluten & Dairy Free

FormBlends physicians specialize in both

Today BC Pharmacare announced coverage of semaglutide (Ozempic), a once-a-week shot, for individuals living with Type 2 diabetes on oral medication alone (metformin & glyburide) or on insulin plus metformin

Based on this observation, one might infer that increased fish consumption could heighten the risk of IBD